Dr. Dennis Anthony Debias, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1000 Gravel Pike, Suite 400, Schwenksville, PA 19473 Phone: 610-287-6650 Fax: 610-287-6652 |
Dr. Mary Alex Kadysh, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 102 Memorial Dr, Schwenksville, PA 19473 Phone: 610-287-8129 Fax: 610-287-0359 |
Daniel C Lyons, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1220 Chase Lane, Schwenksville, PA 19474 Phone: 215-219-7721 |
York Chiang Yang, M.D Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 102 Memorial Dr, Schwenksville, PA 19473 Phone: 610-287-8129 Fax: 610-287-0359 |
Alan Keiser, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 596 Main St, Schwenksville, PA 19473 Phone: 610-287-8129 |
News Archive
The African Union (A.U.) "held a rare fundraiser in Ethiopia Thursday in a bid to plug a $1.1 billion shortfall in aid for millions facing starvation in the Horn of Africa's worst drought in decades," Agence France-Presse reports.
Scientists at the Virginia Bioinformatics Institute at Virginia Tech have discovered some of the key molecular events in the immune system that contribute to inflammatory bowel disease. The results, which help researchers move one step further in their efforts to develop new drugs to treat inflammatory and immune-mediated diseases, are reported in the November 2010 edition of the journal Mucosal Immunology from the Nature Publishing Group.
BIOCRATES Life Sciences AG, a global leader in targeted metabolomics, reported today the Alzheimer's Disease Metabolomics Consortium's new breakthrough in Alzheimer's research, which connects the Gut-Liver-Brain axis in the development and progression of Alzheimer's disease (AD). During the Alzheimer's Association International Conference, Chicago, USA, researchers reported new data on how gut bacteria and lipid metabolism may influence AD.
FUJIFILM Medical Systems U.S.A., Inc., a leading provider of diagnostic imaging products and medical informatics solutions, announced it has received FDA 510 (k) clearance for the sale and distribution of its most recent innovation in PACS technology, Synapse 5.
Computer programs designed to help radiologists could identify more cases of breast cancer, but they might also increase the number of false-positive results, which can lead to biopsies in healthy women, according to a recent systematic review.
› Verified 6 days ago